Cargando…

Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy

This cross-sectional study was to evaluate the levels of urinary liver-type fatty acid binding protein (u-LFABP pg/mg urine creatinine ratio) at different stages of diabetic nephropathy and to see its correlation with other clinical parameters in South Indian patients with type 2 diabetes mellitus (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viswanathan, V., Sivakumar, S., Sekar, V., Umapathy, D., Kumpatla, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588321/ https://www.ncbi.nlm.nih.gov/pubmed/26628791 http://dx.doi.org/10.4103/0971-4065.145097

Ejemplares similares

Clinical Significance of Urinary Liver-Type Fatty Acid–Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients
por: Kamijo-Ikemori, Atsuko, et al.
Publicado: (2011)

Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
por: Panduru, Nicolae M., et al.
Publicado: (2013)

Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis
por: Zhang, Li, et al.
Publicado: (2022)

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
por: Nielsen, Stine Elkjaer, et al.
Publicado: (2010)

Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study
por: Viswanathan, Vijay, et al.
Publicado: (2012)

Urinary Podocyte-Associated mRNA profile in Various Stages of Diabetic Nephropathy
por: Zheng, Min, et al.
Publicado: (2011)

Urinary liver-type fatty acid binding protein and chronic kidney disease
por: Kamijo-Ikemori, A., et al.
Publicado: (2015)

The Role of Urinary Liver-Type Fatty Acid-Binding Protein in Critically Ill Patients
por: Cho, Eunjung, et al.
Publicado: (2013)

Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner
por: Kitada, Munehiro, et al.
Publicado: (2017)

Predictive Effects of Urinary Liver-Type Fatty Acid–Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Correction: Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner
Publicado: (2017)

Distinct Roles of Urinary Liver-Type Fatty Acid-Binding Protein in Non-Diabetic Patients with Anemia
por: Imai, Naohiko, et al.
Publicado: (2015)

Renal expression and urinary excretion of liver‐type fatty acid‐binding protein in cats with renal disease
por: Katayama, Masaaki, et al.
Publicado: (2020)

Clinical evaluation of urinary liver-type fatty acid-binding protein for the diagnosis of renal diseases in dogs
por: TAKASHIMA, Satoshi, et al.
Publicado: (2021)

Urinary Markers of Glomerular Injury in Diabetic Nephropathy
por: Cohen-Bucay, Abraham, et al.
Publicado: (2012)

Elevation of urinary liver-type fatty acid binding protein after cardiac catheterization related to cardiovascular events
por: Kamijo-Ikemori, Atsuko, et al.
Publicado: (2015)

Urinary liver‐type fatty acid‐binding protein as a prognostic marker in patients with acute heart failure
por: Sunayama, Tsutomu, et al.
Publicado: (2021)

Urinary liver‐type fatty acid‐binding protein: A hemodynamic index during extracorporeal membrane oxygenation
por: Ichibayashi, Ryo, et al.
Publicado: (2022)

Relationship between Urinary Liver-Type Fatty Acid-Binding Protein (L-FABP) and Sarcopenia in Spontaneously Diabetic Torii Fatty Rats
por: Tanabe, Jun, et al.
Publicado: (2020)

Significance of urinary albumin excretion in patients with cast nephropathy
por: Nakagawa, Ryo, et al.
Publicado: (2019)

Circulating Levels of Adipocyte and Epidermal Fatty Acid–Binding Proteins in Relation to Nephropathy Staging and Macrovascular Complications in Type 2 Diabetic Patients
por: Yeung, Dennis C.Y., et al.
Publicado: (2009)

Urinary liver‐type fatty acid‐binding protein is independently associated with graft failure in outpatient kidney transplant recipients
por: Yepes‐Calderón, Manuela, et al.
Publicado: (2020)

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis
por: Torigoe, Kenta, et al.
Publicado: (2020)

Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report
por: Takashima, Satoshi, et al.
Publicado: (2022)

Current Metabolic Status Affects Urinary Liver-Type Fatty-Acid Binding Protein in Normoalbuminuric Patients With Type 2 Diabetes
por: Ito, Hiroyuki, et al.
Publicado: (2017)

Fatty acid binding profile of the liver X receptor α
por: Bedi, Shimpi, et al.
Publicado: (2017)

The Various Roles of Fatty Acids
por: de Carvalho, Carla C. C. R., et al.
Publicado: (2018)

The Physiologic Significance of Early Urinary Intestinal Fatty Acid Binding Protein Levels in Preterm Infants: A Prospective Cohort Study
por: Jung, Young-Hwa, et al.
Publicado: (2021)

Urinary Intestinal Fatty Acid-Binding Protein Can Distinguish Necrotizing Enterocolitis from Sepsis in Early Stage of the Disease
por: Coufal, Stepan, et al.
Publicado: (2016)

Significance of Urinary Full-Length Megalin in Patients with IgA Nephropathy
por: Seki, Takuto, et al.
Publicado: (2014)

A pilot study on the effects of a polyherbal formulation cream on diabetic foot ulcers
por: Viswanathan, Vijay, et al.
Publicado: (2011)

Urinary Liver-Type Fatty-Acid-Binding Protein Predicts Long-Term Adverse Outcomes in Medical Cardiac Intensive Care Units
por: Naruse, Hiroyuki, et al.
Publicado: (2020)

Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease
por: Mitsides, Nicos, et al.
Publicado: (2023)

Urinary liver‐type fatty acid‐binding protein in clinically healthy elderly cats: Evaluation of its potential to detect IRIS stage 1 chronic kidney disease and borderline proteinuria
por: Kongtasai, Thirawut, et al.
Publicado: (2022)

The Biological Functions and Regulatory Mechanisms of Fatty Acid Binding Protein 5 in Various Diseases
por: Xu, Binyue, et al.
Publicado: (2022)

Effect of a polyherbal formulation cream on diabetic neuropathic pain among patients with type 2 diabetes – A pilot study
por: Viswanathan, Vijay, et al.
Publicado: (2016)

Study on the correlation between urinary retinol-binding protein and nonalcoholic fatty liver disease
por: Li, Chuang, et al.
Publicado: (2021)

Knowledge and Outcome Measure of HbA1c Testing in Asian Indian Patients with Type 2 Diabetes from a Tertiary Care Center
por: Kumpatla, Satyavani, et al.
Publicado: (2010)

Urinary liver-type fatty acid-binding protein variation as a predictive value of short-term mortality in intensive care unit patients
por: Suzuki, Ginga, et al.
Publicado: (2021)

Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy
por: Yoon, Soo-Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dqahjukg1e0osrgite9arnjj5i